ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0036376;sodium ion export across plasma membrane;9.0;1.0;0.896240625180289;9.628524252492122;131.16583792001737;7.138016298065211;0.004390002553592762;0.7612791106150483;[FXYD2, ATP1B2, ATP1B1, SLC8A1]
GO:0032692;negative regulation of interleukin-1 production;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.65969381209598;6.518977089658987;0.002197570862002862;0.6565011041187423;[IL10, GHSR, IL1R2, NR1H4, TNFAIP3, PML, NLRP12, CEACAM1, NLRP3]
GO:1904179;positive regulation of adipose tissue development;6.0;1.0;0.8231203125901445;9.628524252492122;84.15966440839325;8.16763571524637;0.0028167482289683326;0.7408135829017477;[NR1H4, SIRT1]
GO:0009313;oligosaccharide catabolic process;5.0;0.6763753087927167;0.6284286662572787;8.458452999841867;68.60352119966694;7.069023426578259;0.0022960981153922187;0.6517511986393402;[GM2A, SLC3A1, GBA3]
GO:0006682;galactosylceramide biosynthetic process;10.0;1.0;0.9152410118609203;9.628524252492122;1990.8957052011376;8.16763571524637;0.06663348756327375;0.8329342821725234;[GAL3ST1]
GO:0042136;neurotransmitter biosynthetic process;5.0;0.7043150770688792;0.6423985503953599;8.673012807464685;62.1623008145898;6.015873511986907;0.002080516265825678;0.5978930630306589;[ACHE, GCH1, AGXT2, SLC22A2, SLC1A3, RORA, UPB1, SLC5A7, DPYD, AKT1, CYP1B1]
GO:1902714;negative regulation of interferon-gamma secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.9724324201893;8.67846133901236;0.02523477878196853;0.8590579283277371;[NR1H4]
GO:0003333;amino acid transmembrane transport;9.0;0.5756379274792419;0.68405958891991;8.302854513188667;195.84914281057607;5.500407508664414;0.006554894557084751;0.6775317209684948;[SLC43A2, SLC1A3, SLC3A1, SLC38A11, SLC7A11, SLC1A6, SLC38A6, SLC17A6, SLC36A1, SLC38A1, SLC6A16, SLC6A15, SLC6A12, SLC6A6, SLC7A5, SLC7A7, SLC7A8, SLC7A9]
GO:0009436;glyoxylate catabolic process;8.0;1.0;0.875;9.628524252492122;384.6553950540362;8.67846133901236;0.012874069905078132;0.8188169164668168;[AGXT2]
GO:0019481;L-alanine catabolic process, by transamination;12.0;1.0;0.9481203125901445;9.628524252492122;646.8080282988005;9.777073627680469;0.02164808261772783;0.9481203125901445;[AGXT2]
GO:0019482;beta-alanine metabolic process;7.0;0.7980440201809971;0.7499413753476991;9.370695143190021;112.21837679303422;8.390779266560578;0.0037558480812805665;0.7800242071602487;[DPYS, DPYD, UPB1]
GO:0071417;cellular response to organonitrogen compound;5.0;0.5326392268888578;0.5565606253053492;7.373192044348622;128.5302829088889;3.7981878627793475;0.004301792899215809;0.4844805157972549;[CYFIP1, IL1RN, AQP9, AQP1, AKT1, PRKACB, MEF2C, PRKCD, POR, ADCY9, PRKAR1B, KCNQ1, RRAGD, CFTR, ABCB4, FPR2, SLC30A10, PRKAR2B, PDGFD, PDGFC, EGR1, JUP, CDC6, COL1A1, COL1A2, ID1, NOX4, EZH2, GABRB1, BRCA1, CD36, EDN1, ARG1, CEACAM1, TLR6, TLR4, PTAFR, PTGS2, PAK1, CTNNA1, NR1H4, SORBS1, COL3A1, TNF, SLC8A1, SESN3, CDH1, MEN1, GHSR, PDGFRA, LHCGR, IGFBP5, COL4A1, BLM, ADRB2, FOXO1, NLRP3, TGFB1, CAV1, NFKB1, NR4A2, NR4A1, NR4A3, COL5A2, SLC26A3, FBN1, BCL2L1, LRRK2, TREM2, PTPN22, GRM5, PDE4B, MMP2, GLP2R, DNM2, CCNA2, COL6A1, CEBPB, LRP1, NOD2, FYN, CSK, SNCA, KLF4, TSHR, KLF1, MAPK13, RAD51, KLF5, FCGR2B]
GO:0050435;amyloid-beta metabolic process;6.0;0.9326813400603323;0.7894609826203107;9.533214072687796;60.01596331221528;6.943860283624253;0.0020086802811995464;0.6782296504172152;[ACE, NAT8, MME, PSEN2, APEH]
GO:0035435;phosphate ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;110.11210983553856;7.138016298065211;0.003685353221730381;0.7400384854347593;[ANKH, SLC17A1]
GO:0042426;choline catabolic process;8.0;1.0;0.875;9.628524252492122;257.1096326794824;7.9853141584524145;0.008605228022135562;0.7833693374183408;[DMGDH, BHMT, SLC44A1]
GO:0046628;positive regulation of insulin receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.517298617381897;293.6040497598144;7.069023426578259;0.009826663318971241;0.7124295520356204;[NR1H4, SIRT1, PRKCZ, GNAI2]
GO:1904064;positive regulation of cation transmembrane transport;8.0;0.6007507099811141;0.675375354990557;8.20713857156096;171.06638151308826;4.981283082083729;0.0057254378394949665;0.6297430484711148;[CXCL9, CTSS, JPH2, EPHB2, KCNH2, TRPC1, F2R, ACTN4, ATP1B2, PDZK1, ATP1B1, DNM2, KCNQ1, XCL1, SHANK3, KCNE3, ADRB2, THY1, CD19, FLNA, DMD, PLCG1, DRD4, SNCA, CXCL10, CXCL11, EHD3, F2RL3]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[, NUP107, PRKACB, CLDN3, PADI4, PDGFC, ABCA1, JUP, FN1, COL1A1, COL1A2, HLA-DRB1, ACHE, DPYS, ARHGAP6, CHAF1B, CHAF1A, KCND2, ARG1, F5, SLC7A7, SLC7A9, KCNA5, CENPA, HLA-DMA, HLA-DMB, DMD, CENPE, CENPF, CENPH, CENPI, CENPK, CENPL, CENPM, GOPC, CENPN, CENPO, KCNG2, GMNN, RUVBL2, RUVBL1, OLFM4, BLM, UQCRB, LIN7A, ACAT1, CXCL12, HLA-DRA, LRRK2, ALAD, VBP1, NDUFC2, ACPP, BDP1, BIRC3, NDUFB7, NDUFB6, HM13, NDUFB4, NDUFB3, NDUFB2, NDUFB1, CCL5, EIF4H, NDUFA8, NDUFA7, NDUFA6, NDUFA3, NDUFA2, IL2RB, CD247, EIF3D, CCNH, PRF1, IKZF1, TCL1A, SNRPD2, SNRPD1, TNFSF11, FBXO5, SNRPD3, HNF1B, MIF, KCTD12, KCTD15, TGFA, PTK2, CD40, CTSZ, CD3G, CD3E, CD3D, CCT3, CCT2, FCER1G, YAP1, NAPA, MIS12, CAPG, CCT8, CD74, GCH1, RPA1, RPA3, NDUFAB1, NDUFB10, NDUFB11, TCF7, RASGRP1, CCNB1, H1FX, ECT2, CAV2, UBE2C, CAV1, HMGA1, VIL1, NASP, TCF4, HMGB2, TNFAIP3, LAMC1, NUP62, GREM1, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NUP54, FBP1, TAF9, SAMHD1, RRM1, EGF, MX2, SOD2, TTC19, TEK, CDA, BIN2, NUP205, PRKCZ, ACMSD, HMOX1, NCKAP1L, EHD3, SERPINA1, TK1, BRD2, GSN, GTF2H1, TNF, CLU, DACH1, MEN1, TLE4, SNRPG, SNRPE, SNRPF, ITPR3, NACC2, LSM3, HOPX, CDK1, EMILIN1, ADSL, VWF, TRAF1, PTBP2, MCM2, NLGN1, NLRC4, NOD2, PLN, WASF3, PML, MARCKS, RAD51, P2RX1, IMPDH2, PPP2R1A, MCCC2, COX7A2L, TLN1, MGST1, CD79B, CD79A, VASP, AHCTF1, RAD51C, UQCR10, CTNNA1, NDUFA11, KNTC1, CHRNB4, ADRB2, NLRP3, MYH11, TGFB1, EIF2S1, H2AFX, AXIN2, DNM2, TGFBR3, COL6A2, COL6A1, COLEC12, CAMK2D, HIST1H2BK, LEF1, HSPD1, REPS2, RBMX]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[TNFAIP6, TNFAIP3, RORA, ETS1, CDH5, DUSP10, IL10, GHSR, IL1R2, PRKCD, TNFRSF1B, ADCYAP1, CALCRL, NLRC3, GATA3, NT5E, NLRP3, ELANE, NR1H4, KLF4, NFKB1, NLRP12, TEK, FCGR2B]
GO:0006212;uracil catabolic process;9.0;1.0;0.896240625180289;9.628524252492122;1126.0761526232816;9.083926447120524;0.03768875542555955;0.8607930461318132;[DPYS, DPYD]
GO:0006210;thymine catabolic process;9.0;1.0;0.896240625180289;9.628524252492122;1047.620013338454;8.67846133901236;0.03506289904963761;0.8400575416471059;[ALDH6A1, DPYS, DPYD]
GO:1903017;positive regulation of exo-alpha-sialidase activity;6.0;1.0;0.8231203125901445;9.628524252492122;49.74292023502716;9.777073627680469;0.0016648507745445841;0.8231203125901445;[GBA3]
GO:1904985;negative regulation of quinolinate biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;336.1945481689839;9.777073627680469;0.011252128971766102;0.8509193652572005;[ACMSD]
GO:0046500;S-adenosylmethionine metabolic process;5.0;0.8436909121759173;0.712086467948879;9.34084218004034;77.78999551895997;7.212124270218933;0.002603561143568827;0.659069382437994;[BHMT2]
GO:1904468;negative regulation of tumor necrosis factor secretion;10.0;1.0;0.9152410118609203;9.628524252492122;776.4370852710225;7.8311634786251565;0.02598665049601094;0.8157270763441555;[GHSR, NR1H4]
GO:0006579;amino-acid betaine catabolic process;5.0;0.811012628672052;0.6957473261969462;9.32314260294094;168.34888799976662;8.67846133901236;0.005634485777189472;0.7340579283277371;[DMGDH, BHMT]
GO:0007269;neurotransmitter secretion;8.0;0.7043150770688792;0.7271575385344395;8.771074020640901;61.60461712537578;6.113511981550823;0.00206185109463042;0.6876452870438905;[SLC5A7, SLC22A2, LIN7A]
GO:0090181;regulation of cholesterol metabolic process;7.0;0.8259837884571596;0.7639112594857803;9.405380701177911;31.920461027636424;5.8067817141283475;0.0010683491040451517;0.6478784521606894;[DGAT2, NR1H4, ELOVL6, POR, SCD, RAN]
GO:0032715;negative regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.96654663153603;6.166155715036245;0.002174371849661483;0.6384578026126634;[ORM1, TNFAIP3, PTPN22, NLRC3, TNF, INPP5D, NCKAP1L, CSK, HAVCR2, SLAMF1, IL10, GHSR, NR1H4, IRAK3, NLRP12, BANK1, BPI, TLR4]
GO:0006569;tryptophan catabolic process;9.0;0.8436909121759173;0.8180860812682478;9.539576766475626;1971.8984750997497;7.474488534686424;0.06599766736817739;0.7784863164434164;[KMO, ACMSD]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[CDA, CYFIP1, CPNE5, KIAA1109, PPP2R1A, DPYSL2, RPS6KA1, AKT1, SFRP2, MAP1B, AGTR1, PRKCQ, EPB41L3, SFN, FN1, FXYD2, NRP1, CDKN1A, ARHGAP4, ESM1, HNF4A, CD38, EDN1, AVPR1A, SIRT1, IL17RB, CEACAM1, SGK1, HBEGF, PAK1, FRZB, SPP1, CDKN2C, KIF26A, SIPA1, SEMA5B, CTGF, CXCL16, TNR, SEMA6A, IGFBP5, IGFBP3, S100A8, HTRA1, SOCS2, IGFBP7, TGFB2, TGFB1, SYT2, CRIM1, INHBA, CXCL12, BCL6, BCL2, CYR61, TCHP, MYOCD, DCC, DNM2, GREM1, PSRC1, NDUFS3, FBP1, CAMK2D, TAF9, LEF1, RAB21, SEMA4B, PML]
GO:2000649;regulation of sodium ion transmembrane transporter activity;9.0;0.7140352122741334;0.7532582313173557;9.105276108727574;122.59439798633444;5.8650506222523235;0.004103124172807513;0.6961795867550195;[CAMK2D, DMD, DRD4, YWHAH, PRKCE, ACTN4, ATP1B1, DNM2, FXYD2, FXYD6]
GO:0034971;histone H3-R17 methylation;11.0;1.0;0.9324289523296623;9.628524252492122;765.1744145876387;9.083926447120524;0.025609699043983632;0.8969813732811862;[NR1H4]
GO:0035543;positive regulation of SNARE complex assembly;8.0;1.0;0.875;9.628524252492122;341.3684633423411;9.777073627680469;0.011425295256397018;0.875;[TMEM27]
GO:0015711;organic anion transport;6.0;0.43219213062620165;0.5392163779032453;6.26616670414623;28.19857810171702;3.758480413184235;9.437810319917961E-4;0.5153291757075998;[SLC35B3, AQP9, SLC4A1, SLC4A3, AQP1, ACSL1, SLC6A16, SLC11A1, SLC6A15, SLC6A13, SLC6A12, CFTR, SLC22A4, ABCB4, SLC22A2, SLCO5A1, SLC19A2, ABCA1, ACE, SLC10A2, SLC16A14, SLC6A6, SLC7A11, SLC22A15, CD36, SLC22A11, ANXA1, SLC7A5, CEACAM1, SLC7A7, SLC7A8, SLC7A9, SLC43A2, SLC17A6, SLC17A1, SLC17A3, PNPLA8, NR1H4, FABP1, XK, SLCO4C1, RHAG, ATP8A1, BEST1, SLCO2B1, SLC26A11, SLC16A3, SLC16A4, SLC38A1, ATP11C, SLC27A2, SLC1A3, SLC38A11, SLC1A6, PSAP, SLC38A6, DRD4, ATP8B4, ATP8B2, SLC26A8, SLC26A7, SLC26A3, SERINC5, SLC2A2, CA2, CA4, SLC36A1, ABCC3, SLC13A1, SLC3A1, ATP10B, LRP2, SLC25A21, ATP9A, SLC35A3, SLC4A7, FOLR3]
GO:0051259;protein complex oligomerization;5.0;0.7763722522362496;0.6784271379790451;9.089527751759436;40.42272244673708;3.6012063575747084;0.0013529121422039536;0.47440687246051283;[CDA, PRF1, IKZF1, TCL1A, TNFSF11, MCCC2, MIF, CLDN3, KCTD12, KCTD15, MGST1, PRKCZ, ACMSD, CD79B, CD79A, HMOX1, VASP, JUP, COL1A1, EHD3, COL1A2, ACHE, DPYS, CD3G, CD3E, CD3D, TK1, FCER1G, KCND2, ARG1, KCNA5, CTNNA1, CD74, GCH1, GOPC, KCNG2, CHRNB4, OLFM4, BLM, ITPR3, RASGRP1, ACAT1, NACC2, NLRP3, ECT2, CAV2, CAV1, TNFAIP3, ALAD, NUP62, EMILIN1, ADSL, VWF, COL6A2, COL6A1, NUP54, ACPP, FBP1, BIRC3, COLEC12, NLGN1, CAMK2D, HM13, NLRC4, NOD2, SAMHD1, PLN, CCL5, RRM1, SOD2, MARCKS, RAD51, P2RX1, IMPDH2, TEK, CD247, RBMX]
GO:0072615;interleukin-17 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;137.06961104194002;9.083926447120524;0.004587596526932657;0.8797934328124444;[NR1H4]
GO:0036112;medium-chain fatty-acyl-CoA metabolic process;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;93.60244388508701;8.390779266560578;0.0031327895601034775;0.7800242071602487;[HSD17B4, ACSM2A]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[ITGB2, PTGS2, TNF, CLU, KLRK1, AKT1, CD36, EDN1, AGXT2, KLF4, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:0090314;positive regulation of protein targeting to membrane;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;497.0805077511855;6.343086423195323;0.016636837251019197;0.7396267465268138;[, ITGAM, ITGB2, PDZK1, PAK1, FYN]
GO:0046477;glycosylceramide catabolic process;9.0;0.8933024483968273;0.8428918493787028;9.567899630675686;1347.1201103546368;7.9853141584524145;0.04508689776418146;0.8046099625986299;[GBA3]
GO:0022900;electron transport chain;4.0;0.7140352122741334;0.6070176061370667;8.475844742553736;29.758801740447502;4.623782033182691;9.96000313069993E-4;0.48646042820481683;[DMGDH, COX6A1, LOXL2, COX6B1, POR, COX7A2L, UQCRC1, NDUFB10, UQCRB, UQCRH, CYC1, UQCRQ, P4HA2, NOX4, COX7B, ETFA, COX7C, UQCRFS1, COX8A, GPX2, NDUFC2, NDUFS8, NDUFS7, ASPH, NDUFS6, NDUFS4, NDUFS3, NDUFB7, NDUFB6, NDUFB4, NDUFB3, NDUFB2, NDUFB1, UQCR10, COX5B, COX5A, SNCA, NDUFA8, NDUFA7, NDUFA6, NDUFA4, NDUFA3, NDUFA2, COX6C, NDUFAB1]
GO:0043124;negative regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;6.063501560976162;0.008015432820232688;0.6850877518099798;[TNFAIP3, RORA, NLRC3, PYCARD, NR1H4, RHOH, SIRT1, NLRP12, CCDC22, ZMYND11]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[EHF, PID1, SPI1, SERPINE1, SPIB, MYB, HOXA3, AKT1, HOXA2, HOXA7, JUNB, HOXA5, MEF2A, MED1, MEF2C, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, ATF3, HOXB5, GATA3, GATA1, NKX2-3, JUN, JAG1, JUP, FZD5, FZD8, HOXC10, PAX5, FOS, SIRT1, PAX2, MMP12, PLSCR1, RARA, ENG, NR1I2, EPCAM, STAT4, NR1H2, ATAD2, NR1H4, GTF2H1, POU4F1, PSMC6, PSMC2, FOSB, PF4, CCNT2, PLXND1, RORA, TNF, RUVBL2, MEN1, ADCYAP1, FOXO1, NFKB1, NFKB2, CXCL10, COPS5, MAFF, BCL3, CIITA, CYR61, HHEX, PPP1R12A, CHUK, PEG3, TFDP1, CEBPB, CEBPE, NOD2, ABLIM3, E2F1, E2F2, E2F5, E2F7, PRRX1, KLF4, PML, KLF1, KLF6, KLF5, POU2AF1, CCNH, IKZF1, RPS6KA1, TNFSF11, DPF3, SOX4, SLC11A1, EBF1, FLT3LG, HNF1B, RUNX2, SFRP2, IL23A, BEX1, TXK, TWIST1, NHLH2, EGR1, EGR2, EGR3, BCL11B, LIF, CD28, TOP2A, CD40, HNF4G, PRL, BRCA1, CD3D, HNF4A, IL10, EDN1, IL18, RGMA, IL1A, IL1B, TFEC, TLR4, TLR2, YAP1, SATB2, IL33, CDX1, LILRB1, GRHL2, CAMK1, FOXA3, IL17A, FOXA2, IHH, ARID4A, ARID4B, ETS1, HOXA10, EOMES, ADRB2, NLRP3, TGFB2, TGFB1, VDR, HMGA1, INHBA, NR4A2, NFKBIA, NR4A1, IL6, BMP2, NR4A3, TCF4, HMGB2, SLC40A1, ARHGEF10L, MYBL1, MYOCD, KLF13, DDX58, CKAP2, ETV1, DCN, GREM1, ELF3, IRF7, TAF9, LEF1, DLL1, LUM, MAPK14, MEIS2, MEIS1, RBMX]
GO:0008206;bile acid metabolic process;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;102.42028116817174;6.166155715036245;0.003427914638429987;0.6662568552797195;[OSBPL7, NR1H4, HSD17B4, CH25H, SLC27A2]
GO:0043401;steroid hormone mediated signaling pathway;6.0;0.7508913569872202;0.6985659910837546;8.801845679307654;25.735219620490994;4.909539177224887;8.613346405038622E-4;0.5741943744303455;[TGFB1I1, FHL2, HNF4G, RORA, BRCA1, NR3C2, HNF4A, YWHAH, MED1, CCNE1, RARA, PADI2, YAP1, NR1I2, LEF1, VDR, NR1H2, NR1H4, DEFA1, NR2F2, NR4A2, NR4A1, NR4A3, RAN]
GO:0006544;glycine metabolic process;9.0;0.7508913569872202;0.7716863036738992;9.223059144383958;140.0586125355607;6.832634648514029;0.004687635716997441;0.7456618788553018;[AGXT2, GLYAT, GART]
GO:0032703;negative regulation of interleukin-2 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.7325511899570465;0.002184000309729388;0.6674232935401965;[LAG3, TBX21, NR1H4, XCL1, TNFAIP3, HOMER3, GATA3, CD34, HAVCR2]
GO:0072488;ammonium transmembrane transport;7.0;0.7763722522362496;0.7391054913753253;9.193206181234276;79.759283350777;7.069023426578259;0.002669471435055758;0.7124295520356204;[SLC22A4, SLC12A2, SLC22A2, RHAG, RHCE, AQP1]
GO:0071398;cellular response to fatty acid;6.0;0.7369933605727446;0.6916169928765168;9.004369943419128;203.00017448222317;5.8067817141283475;0.006794233151624104;0.6200793994936333;[PID1, PTGER2, PTAFR, TNC, P2RY6, CCNB1, E2F1, AKT1, FFAR2, PTGDR, EDN1, DGAT2, PRKCE, NR1H4, NME1, IL1B]
GO:1990822;basic amino acid transmembrane transport;10.0;0.7508913569872202;0.7906866903545304;9.277126365654233;267.5048622669104;7.697632086000634;0.008953147001327533;0.8088982747154926;[SLC7A7, SLC3A1]
GO:0043252;sodium-independent organic anion transport;7.0;1.0;0.8509193652572005;9.628524252492122;31.887457555831563;6.444869117505266;0.0010672445075450394;0.6805102716434839;[SLCO2B1, SLCO4C1, SLCO5A1, SLC22A11]
GO:0033477;S-methylmethionine metabolic process;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;66.57740480436925;9.777073627680469;0.0022282858230279765;0.7902410118609202;[BHMT2]
GO:0035774;positive regulation of insulin secretion involved in cellular response to glucose stimulus;11.0;1.0;0.9324289523296623;9.628524252492122;1297.4197001833559;6.375876246018314;0.043423469763213894;0.7584915600596062;[NR1H4, TMEM27, CFTR]
GO:0032787;monocarboxylic acid metabolic process;6.0;0.4041121164096334;0.5251763707949613;6.17325964955969;45.970157814142674;3.5745381104925467;0.00153857981158332;0.505922357793755;[, ACSM5, CYP1B1, MCCC2, ACSL1, ACSL5, MIF, CH25H, POR, MGST1, ACMSD, C3, PRKAR2B, CYP4F2, CYP4F3, FA2H, HAL, VNN1, VNN2, VNN3, TECR, BRCA1, ACADM, EDN1, ELOVL4, BGN, ELOVL6, ELOVL7, ACSBG1, HSD17B4, PTGS2, PTGS1, ALOX5, CD74, PNPLA8, NR1H4, NDUFAB1, PLP1, SCARB2, SLC16A3, UGT2B15, UGT2B17, PGD, SLC27A3, SLC27A2, SLC1A3, GLYAT, ACAT1, OSBPL7, AGXT2, CYP4F12, NR4A3, TBXAS1, CSPG4, ACSM2A, ETFA, GHR, HK3, DSE, UGT2A3, HIBCH, CYP4A11, BPGM, PRODH2, DCN, VCAN, NDUFS6, EHHADH, UGT2B28, CYP3A4, SNCA, MAPK14, SCD]
GO:1905695;positive regulation of phosphatidic acid biosynthetic process;10.0;1.0;0.9152410118609203;9.628524252492122;793.8405856554135;9.777073627680469;0.026569129991743035;0.9152410118609203;[NR1H4]
GO:0034162;toll-like receptor 9 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;7.004484905440688;0.013811191226989502;0.8063299963962409;[UNC93B1, NR1H4, TLR8, TLR7, MYD88, HAVCR2]
GO:0070858;negative regulation of bile acid biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;863.7365953682863;8.390779266560578;0.02890848653450811;0.8253454670833372;[NR1H4]
GO:0055089;fatty acid homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;32.348635705990986;7.138016298065211;0.0010826797251974863;0.7159578506919597;[DGAT2, POLD1, NR1H4, SIRT1]
GO:0008295;spermidine biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;340.8203908116312;8.67846133901236;0.011406951762027414;0.8400575416471059;[AGMAT]
GO:0045956;positive regulation of calcium ion-dependent exocytosis;10.0;0.7763722522362496;0.8034271379790452;9.31486669363708;302.859176005535;6.7325511899570465;0.010136424065342656;0.7595439928109722;[NLGN1, TMEM27]
GO:0046135;pyrimidine nucleoside catabolic process;8.0;0.7307253602413294;0.7403626801206646;9.333724712271477;1255.5710096994353;6.686031174322154;0.04202283175409332;0.7169239451870815;[CDA, DPYS, UPB1, NT5E, DPYD, UPP1]
GO:0071267;L-methionine salvage;12.0;0.8653626801206646;0.8808016526504769;9.54628615425515;1471.4566970700218;7.697632086000634;0.04924833142588224;0.8417775754447168;[BHMT, BHMT2]
GO:0010804;negative regulation of tumor necrosis factor-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;306.2706419112467;6.7325511899570465;0.010250602759086841;0.719302980950052;[NR1H4]
GO:0010248;establishment or maintenance of transmembrane electrochemical gradient;6.0;1.0;0.8231203125901445;9.628524252492122;27.942148572769092;7.212124270218933;9.351985664295021E-4;0.6919486831672181;[FXYD2, ATP1B2, ATP1B1]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, SIRPA, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, PRTN3, ADAM8, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, SLC7A9, IL1B, CEACAM5, KIT, PECAM1, XCL2, XCL1, CEACAM8, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR3, TBX21, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0051957;positive regulation of amino acid transport;8.0;0.6913464685778243;0.7206732342889122;8.904605413265422;216.79203129020456;6.8867018697843045;0.00725583418712196;0.7271862538851576;[TMEM27, AVPR1A, KMO]
GO:0018003;peptidyl-lysine N6-acetylation;11.0;1.0;0.9324289523296623;9.628524252492122;471.0153561828549;9.083926447120524;0.015764460085140618;0.8969813732811862;[NAT8]
GO:0015812;gamma-aminobutyric acid transport;9.0;0.8436909121759173;0.8180860812682478;9.434368238051164;135.2317479943229;7.697632086000634;0.004526084904698269;0.7898978880348613;[SLC6A13, SLC6A12]
GO:0032414;positive regulation of ion transmembrane transporter activity;8.0;0.6467165523344657;0.6983582761672329;8.744321835169467;245.33187081656047;5.322726331426962;0.008211036931881077;0.6472044721212626;[KCNE3, PTAFR, ADRB2, CTSS, JPH2, DMD, EPHB2, DRD4, ACTN4, ATP1B2, PDZK1, ATP1B1, DNM2, EHD3, SHANK3, CFTR]
GO:0015811;L-cystine transport;10.0;0.9326813400603323;0.8815816818910864;9.571365838652174;254.95955250308688;8.390779266560578;0.008533266773578137;0.8443458537639685;[SLC7A9, SLC3A1]
GO:0015874;norepinephrine transport;7.0;0.8653626801206646;0.7836007053175329;9.427853557029971;50.49597971905488;8.390779266560578;0.0016900549977654571;0.7800242071602487;[SLC22A2]
GO:2001250;positive regulation of ammonia assimilation cycle;10.0;1.0;0.9152410118609203;9.628524252492122;563.8713818606061;9.777073627680469;0.01887226769957734;0.9152410118609203;[NR1H4]
GO:0015872;dopamine transport;7.0;0.811012628672052;0.7564256795932265;9.420884887713877;98.47434876190846;7.212124270218933;0.0032958478319009632;0.7197477358342742;[SLC22A2, SNCA]
GO:0006487;protein N-linked glycosylation;8.0;0.7980440201809971;0.7740220100904985;9.34084218004034;176.5615275388073;5.500407508664414;0.005909355431665436;0.6562910957882058;[ST6GALNAC2, GAL3ST1, ASGR1, ASGR2, KRTCAP2, ALG8, ST3GAL6]
GO:0006520;cellular amino acid metabolic process;6.0;0.406884124246779;0.526562374713534;6.526182243879872;77.81072980309767;4.002522082136061;0.0026042551013992716;0.5278094780068945;[CPOX, MCCC2, KMO, UPB1, MTHFD1, PADI4, GMPS, SLC1A3, GLYAT, ACMSD, ACAT1, AGXT2, SLC6A6, HAL, ALDH6A1, BHMT, P4HA2, NOX4, ALDH18A1, SERINC5, HIBADH, DPYS, PFAS, GHR, HNF4A, HIBCH, ARG1, BHMT2, CAD, PRODH2, SLC7A5, SLC7A7, SLC7A8, DPYD, BCAT1, GART, SLC3A1, SLC25A21, AGMAT]
GO:1901787;benzoyl-CoA metabolic process;6.0;0.8933024483968273;0.7697715367885581;9.461470167828956;79.28961856538737;9.777073627680469;0.002653752177359632;0.8231203125901445;[GLYAT]
GO:0045329;carnitine biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;241.98945829510677;8.16763571524637;0.008099169392763998;0.7408135829017477;[BBOX1, ACADM]
GO:0046415;urate metabolic process;5.0;0.8933024483968273;0.736892236059334;9.4949928598676;153.84051102177276;7.212124270218933;0.005148903456427586;0.659069382437994;[SLC17A1, SLC17A3, ABCG2, SLC22A11]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CCNH, RORA, NR3C2, CTGF, MED1, NRBP1, RUNX2, MAML3, MAZ, VDR, NR4A2, NR4A1, NR4A3, TCF4, CDKN1A, HNF4G, HNF4A, MED23, RARA, YAP1, TAF9, NR1I2, POLR2E, E2F2, POLR2I, POLR2J, POLR2K, POLR2L, NR1H2, NR1H4, GTF2H1, TAF5]
GO:0006637;acyl-CoA metabolic process;5.0;0.5902001590945054;0.5853410914081729;7.97986562690474;77.21017702370673;5.244474134527214;0.0025841551403354684;0.5584436629936305;[TECR, ACSM2A, ACSM5, DGAT2, ACSL1, ACSL5, ELOVL6, ELOVL7, SUCLG1, ACSBG1, FAR2, HSD17B4, GLYAT, ACAT1, SCD]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[CDA, DPYS, TK1, ACPP, FBP1, HM13, SAMHD1, CD79A, VASP, SOD2, IMPDH2, CD247]
GO:0015747;urate transport;7.0;1.0;0.8509193652572005;9.628524252492122;46.61312809093599;7.292166977892469;0.0015600994481119112;0.7238411236270654;[SLC17A1, SLC17A3, SLC22A11]
GO:0035356;cellular triglyceride homeostasis;8.0;1.0;0.875;9.628524252492122;50.566380672597894;7.8311634786251565;0.001692411254323797;0.7754860644832351;[DGAT2, NR1H4, SIRT1]
GO:0015760;glucose-6-phosphate transport;7.0;1.0;0.8509193652572005;9.628524252492122;35.11430155034197;7.9853141584524145;0.0011752440720702493;0.7592887026755414;[SLC17A3]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[TNFAIP3, PYCARD, CYP1B1, HAVCR2, IL10, CHUK, IRAK3, SIRT1, NLRC3, PKHD1, NLRP3, NR1H4, KLF4, NFKBIA, NLRP12, CCDC22]
GO:0034142;toll-like receptor 4 signaling pathway;12.0;0.8436909121759173;0.8699657686781033;9.485423408851448;412.6549923027037;6.943860283624253;0.013811191226989502;0.8032296504172152;[ITGAM, PRKCE, ITGB2, NR1H4, LY96, NFKBIA, S100A14, CD14, TLR4]
GO:0038185;intracellular bile acid receptor signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;49.431582979417115;9.777073627680469;0.001654430596784655;0.8231203125901445;[NR1H4]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, GNS, C3, S100A12, NCKAP1L, ELANE, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, ADAM8, SLC27A2, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, FGL2, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, SERPINE1, HP, CXCL13, TNF, MPO, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, PRKCD, RNASE6, RNASE3, CLEC4D, SLPI, IL23A, S100A8, SEH1L, C5AR1, KLRK1, NLRP3, S100A12, S100A14, IGHA1, ELANE, DEFA4, PRG2, ISG15, AZU1, DEFA1, PPBP, LYZ, SELP, IL6, BCL3, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, GNLY, STAB1, CTSG, CD36, CAMP, HAVCR2, IL10, FCER1G, SYK, ANXA3, TLR1, FGR, IGHD, LTA, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPB, CEBPE, HIST1H2BK, NLRC4, NOD2, IGKC, CCL20, CARD9, NR1H4, CD4]
GO:0007589;body fluid secretion;5.0;0.7980440201809971;0.6892630219514189;8.999915593069748;24.01032294004463;5.514393750639154;8.036039009155507E-4;0.572247364714141;[SLC22A4, CHRM1, ABCB4, SLC22A2, PRL, AQP1, SOCS2, ATP7B, MED1, EDN1, VDR, CAV1, CAD, NME1]
GO:1990573;potassium ion import across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;262.9545538247555;7.57984905034425;0.008800852272780338;0.8200627852632958;[FXYD2, ATP1B1]
GO:0097055;agmatine biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;79.22646413052941;9.083926447120524;0.002651638455260237;0.7876727335416686;[AGMAT]
GO:0007219;Notch signaling pathway;6.0;0.7763722522362496;0.7113064387082693;8.866384200445225;26.50247477320489;4.99795013456894;8.87013979980389E-4;0.5787157149004503;[TMEM100, HHEX, HNF1B, FCER2, MAML3, PSEN2, KCNA5, DTX3, DLL1, PLN, GMDS, PERP, S1PR3, ZNF423, TGFB1, JAG1, NR1H4, KRT19, BMP2, SNAI2]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, GATA1, C3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, FOS, SIRT1, MMP12, PLSCR1, CKS2, PTAFR, STAT4, SPP1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, RORA, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, MYD88, CIITA, FHL2, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, CCL5, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, IKZF1, TNFSF11, EPHB2, HNF1B, SFRP4, SFRP2, EGR1, EGR2, EGR3, ID1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3E, CD3D, HNF4A, CTSH, CD38, CD36, CD34, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, CD74, IL33, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, ACTG2, EOMES, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, NAT8, TCF4, IL7R, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL1, YWHAH, MYOCD, DDX58, ETV1, ACTA2, CCNA2, GREM1, PSRC1, ELF3, IRF7, CREB5, TAF9, TBX21, RBM38, EGF, MAPK14, CD4, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, UPF3B, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, RARA, ENG, NR1I2, FAM129A, EPCAM, GSN, NR1H2, NR1H4, GTF2H1, POU4F1, PLP1, FOSB, PF4, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, LAMP3, MEN1, MAP2K2, F2R, ADAM2, ADAM8, DAB2, COPS5, MAFF, BCL3, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPB, SMARCD3, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, PML, KLF1, KLF6, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EPB41L4B, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR6, TLR4, TLR2, CDX2, CDX1, LILRB1, GRHL2, CAMK4, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, SLC40A1, KLF13, CKAP2, AXIN2, DCN, DNM2, IFNG, LEF1, DLL1, THBS1, LUM, MEIS2, MEIS1, RBMX]
GO:0051692;cellular oligosaccharide catabolic process;6.0;1.0;0.8231203125901445;9.628524252492122;252.6600380230072;9.083926447120524;0.008456304093358543;0.7876727335416686;[GBA3]
GO:0001080;nitrogen catabolite activation of transcription from RNA polymerase II promoter;12.0;1.0;0.9481203125901445;9.628524252492122;2210.1833700256857;9.777073627680469;0.07397284835886582;0.9481203125901445;[NR1H4]
GO:0015879;carnitine transport;9.0;0.8653626801206646;0.8289219652406215;9.548481544818586;68.76534769843015;7.8311634786251565;0.0023015143026714298;0.7967266896635242;[SLC22A4, PDZK1]
GO:0015697;quaternary ammonium group transport;7.0;0.7508913569872202;0.7263650437508107;9.158520623246385;66.28044104864328;7.069023426578259;0.002218346713373857;0.7124295520356204;[SLC22A4, SLC22A2, PDZK1]
GO:2001275;positive regulation of glucose import in response to insulin stimulus;9.0;1.0;0.896240625180289;9.628524252492122;210.7203529833852;6.832634648514029;0.00705262057834843;0.7456618788553018;[PAK1, NR1H4, SORBS1]
GO:0034255;regulation of urea metabolic process;6.0;0.8653626801206646;0.7558016526504768;9.446202695698167;74.09741451287847;9.777073627680469;0.00247997378040243;0.8231203125901445;[NR1H4]
GO:1905004;picolinic acid biosynthetic process;8.0;1.0;0.875;9.628524252492122;749.5803768269942;9.777073627680469;0.0250877806338577;0.875;[ACMSD]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, RARA, ASCL2, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CIITA, FHL2, FASLG, HHEX, RFC1, PEG3, CEBPB, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, EDN1, PARP9, IL1B, SATB2, CDX2, LOXL2, CHCHD3, EOMES, CCNE1, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0006855;drug transmembrane transport;5.0;0.5781283279524737;0.5793051758371571;7.293149336675085;29.084245973375534;5.407625775213448;9.73423538606871E-4;0.5667872454856517;[ABCB4, SLC22A2, SLC1A3, SLC7A11, LRP2, SLC1A6, AQP1, SLC17A6, SLC17A3, SLC19A2, ABCC3, ABCA8, RHAG, ABCG2]
GO:0019265;glycine biosynthetic process, by transamination of glyoxylate;11.0;1.0;0.9324289523296623;9.628524252492122;682.4518923095058;9.083926447120524;0.022841050668771165;0.8969813732811862;[AGXT2]
GO:0071638;negative regulation of monocyte chemotactic protein-1 production;7.0;1.0;0.8509193652572005;9.628524252492122;88.6386384946749;7.9853141584524145;0.002966655460821204;0.7592887026755414;[NR1H4]
GO:0015721;bile acid and bile salt transport;9.0;0.9326813400603323;0.8625812952104552;9.5544162803384;89.96332036720499;6.375876246018314;0.003010991370958501;0.722303232910233;[ABCC3, SLC10A2, AQP9, NR1H4, CEACAM1, SLCO2B1]
GO:0016139;glycoside catabolic process;6.0;0.7140352122741334;0.6801379187272112;8.712233520617966;75.12934532068766;7.474488534686424;0.0025145115758623713;0.7053660038532718;[FUCA1, GBA3]
GO:1905012;regulation of 'de novo' NAD biosynthetic process from tryptophan;9.0;0.8933024483968273;0.8428918493787028;9.54514264355307;392.97423962223826;9.777073627680469;0.013152494146301806;0.896240625180289;[ACMSD]
GO:0007043;cell-cell junction assembly;5.0;0.7508913569872202;0.6656866903545304;8.817594036275793;53.94372379865016;5.16195311083921;0.0018054478893412883;0.554223534004606;[F11R, GJC1, CDH5, CDH3, POF1B, CDH1, EPB41L3, CTNNA1, ECT2, JUP, NR1H4, LSR, ACTN4, GRHL2, GJB2, CLDN3, CDH11, CD9, PKP3, TLN1, CDH17, VCL]
GO:0006633;fatty acid biosynthetic process;8.0;0.6493065804076676;0.6996532902038338;8.912904216080118;359.8485513982277;5.076593261888053;0.01204380717262807;0.6346172154986847;[TECR, ACSM2A, ACSM5, BRCA1, EDN1, ELOVL4, ELOVL6, MIF, ELOVL7, MGST1, PTGS2, CYP3A4, PTGS1, ALOX5, CD74, PNPLA8, FA2H, SCD, NDUFAB1, PLP1]
GO:0006479;protein methylation;8.0;0.5860072649471136;0.6680036324735568;8.391761625343195;206.79845698774034;4.917261223318797;0.006921358248851439;0.6264689676365554;[, BTG2, EHMT2, SUV39H1, ARID4A, ARID4B, FBL, SNRPD3, MEN1, GSPT1, PRDM16, NR1H4, BHMT, EZH2]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CD80, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, IL10, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, RARA, ADAM9, TLR4, CX3CR1, CD274, CEBPB, CEBPE, KLRK1, STAP1, NLRP3, CCL2, CD14, ABCA1, CCL20, NR1H2, DEFA4, NR1H4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, PF4]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, RARA, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, CYR61, TNFRSF1B, ADAMTS20, BIRC5, BIRC3, CX3CR1, CEBPB, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, IL1RN, SLC46A2, IFIT3, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, CD27, NRP1, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, TEK, NAA15]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, RNASE6, RNASE3, MIF, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, TXK, CFI, GATA3, CD1D, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, PTK2, MARCO, VNN1, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA5, IGKC, CARD9, NR1H4, KIR3DL1, LGR4, C1QC, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, CLEC4D, TYROBP, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0006749;glutathione metabolic process;6.0;0.8436909121759173;0.7449657686781032;9.360260265897443;147.28945980206763;5.71663061713405;0.0049296456676673804;0.6154690682008903;[MGST1, EEF1G, NAT8]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, PSMD3, PRSS3, UQCRC1, PRKCQ, UQCRC2, CFB, CFD, ENPEP, CFI, GATA3, ADAMTS12, C2, C3, ELANE, BARD1, ST14, ACE, HACE1, PLK1, AZU1, TGFB1I1, IFIH1, MMP28, OLR1, ACTL6A, SIRT1, F3, MMP12, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, MMP19, FAM105A, ADAM28, USP1, USP9Y, F11, PSMC6, PSMC2, APEH, IGHG1, RUVBL1, RNF43, FBXW2, CDC25A, ADAM2, ADAM9, ADAM8, ADAM7, CUL5, AEBP1, TMEM27, IGLV1-44, CLCA4, WFS1, DHCR24, NFKB1, COPS5, CDK1, ADAMTS1, ADAMTS20, ASPH, MEP1A, DTL, BIRC3, C1S, C1R, HM13, FGL2, RNF24, GZMA, GZMB, PML, GZMH, GZMM, EIF3F, CDC20, ANPEP, TRIM25, SKP2, CDC34, CFTR, CTSZ, CTSW, BRCA1, PCSK6, CTSS, CTSH, CTSG, CTSB, MME, RNF144B, C1QB, C1QA, CD5L, TMPRSS2, IGKC, PERP, RANBP2, RANBP1, IL33, FAP, MAD2L1, C1QC, IHH, BUB1B, PLAU, PCOLCE, ADAM12, PRTN3, PSMD14, PSEN2, HTRA1, ADRB2, TRHDE, DPP4, CCNB1, NLRP3, TGFB1, UBE2C, ISG15, NFKBIA, IGKV3-20, TNFAIP3, MMP1, DDX58, MMP2, MMP8, MMP9, CCNA2, LTF, AURKB, TBX21, NRIP3, RBMX]
GO:0015739;sialic acid transport;8.0;1.0;0.875;9.628524252492122;68.10037139483991;8.16763571524637;0.0022792581442300838;0.7926932703116032;[SLC17A1, SLC17A3]
GO:0035725;sodium ion transmembrane transport;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;113.92400819162063;5.014899692882714;0.0038129340292226534;0.6314622035107071;[SLC24A2, SLC24A1, SLC24A4, SLC5A10, SLC8A1, SLC17A1, SCN3A, SLC17A3, SCN1A, SLC13A1, SLC12A2, SLC6A16, SLC6A15, SLC12A1, SLC6A13, SLC6A12, ATP1B2, ATP1B1, SLC6A6, FXYD2, CAPS2]
GO:0033388;putrescine biosynthetic process from arginine;10.0;0.8933024483968273;0.861892236059334;9.567899630675686;428.6854390569693;9.777073627680469;0.014347715853389339;0.9152410118609203;[AGMAT]
GO:0050666;regulation of homocysteine metabolic process;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;134.33481970803118;9.083926447120524;0.004496065522139136;0.839552420951524;[BHMT]
